Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 18 de 18
Filter
Add more filters










Publication year range
1.
J Neurotrauma ; 39(3-4): 311-319, 2022 02.
Article in English | MEDLINE | ID: mdl-34913747

ABSTRACT

Ryanodine receptors (RyRs) mediate calcium release from calcium stores and have been implicated in axonal degeneration. Here, we use an intravital imaging approach to determine axonal fate after spinal cord injury (SCI) in real-time and assess the efficacy of ryanodine receptor inhibition as a potential therapeutic approach to prevent intra-axonal calcium-mediated axonal degeneration. Adult 6-8 week old Thy1YFP transgenic mice that express YFP in axons, as well as triple transgenic Avil-Cre:Ai9:Ai95 mice that express the genetically-encoded calcium indicator GCaMP6f in tdTomato positive axons, were used to visualize axons and calcium changes in axons, respectively. Mice received a mild SCI at the T12 level of the spinal cord. Ryanodine, a RyR antagonist, was given at a concentration of 50 µM intrathecally within 15 min of SCI or delayed 3 h after injury and compared with vehicle-treated mice. RyR inhibition within 15 min of SCI significantly reduced axonal spheroid formation from 1 h to 24 h after SCI and increased axonal survival compared with vehicle controls. Delayed ryanodine treatment increased axonal survival and reduced intra-axonal calcium levels at 24 h after SCI but had no effect on axonal spheroid formation. Together, our results support a role for RyR in secondary axonal degeneration.


Subject(s)
Axons/pathology , Calcium/metabolism , Ryanodine Receptor Calcium Release Channel , Ryanodine/antagonists & inhibitors , Spinal Cord Injuries , Spinal Cord/drug effects , Animals , Disease Models, Animal , Intravital Microscopy , Mice , Mice, Transgenic , Spinal Cord Injuries/complications , Spinal Cord Injuries/physiopathology
2.
Br J Pharmacol ; 171(3): 646-62, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24117140

ABSTRACT

BACKGROUND AND PURPOSE: While selective, bitter tasting, TAS2R agonists can relax agonist-contracted airway smooth muscle (ASM), their mechanism of action is unclear. However, ASM contraction is regulated by Ca²âº signalling and Ca²âº sensitivity. We have therefore investigated how the TAS2R10 agonists chloroquine, quinine and denotonium regulate contractile agonist-induced Ca²âº signalling and sensitivity. EXPERIMENTAL APPROACH: Airways in mouse lung slices were contracted with either methacholine (MCh) or 5HT and bronchodilation assessed using phase-contrast microscopy. Ca²âº signalling was measured with 2-photon fluorescence microscopy of ASM cells loaded with Oregon Green, a Ca²âº-sensitive indicator (with or without caged-IP3). Effects on Ca²âº sensitivity were assessed on lung slices treated with caffeine and ryanodine to permeabilize ASM cells to Ca²âº . KEY RESULTS: The TAS2R10 agonists dilated airways constricted by either MCh or 5HT, accompanied by inhibition of agonist-induced Ca²âº oscillations. However, in non-contracted airways, TAS2R10 agonists, at concentrations that maximally dilated constricted airways, did not evoke Ca²âº signals in ASM cells. Ca²âº increases mediated by the photolysis of caged-IP3 were also attenuated by chloroquine, quinine and denotonium. In Ca²âº-permeabilized ASM cells, the TAS2R10 agonists dilated MCh- and 5HT-constricted airways. CONCLUSIONS AND IMPLICATIONS: TAS2R10 agonists reversed bronchoconstriction by inhibiting agonist-induced Ca²âº oscillations while simultaneously reducing the Ca²âº sensitivity of ASM cells. Reduction of Ca²âº oscillations may be due to inhibition of Ca²âº release through IP3 receptors. Further characterization of bronchodilatory TAS2R agonists may lead to the development of novel therapies for the treatment of bronchoconstrictive conditions.


Subject(s)
Bronchodilator Agents/pharmacology , Calcium Signaling/drug effects , Chloroquine/pharmacology , Lung/drug effects , Muscle, Smooth/drug effects , Quinine/pharmacology , Receptors, G-Protein-Coupled/agonists , Airway Resistance/drug effects , Animals , Caffeine/antagonists & inhibitors , Caffeine/pharmacology , Calcium Channel Blockers/chemistry , Calcium Channel Blockers/pharmacology , Drug Resistance/drug effects , Female , In Vitro Techniques , Inositol 1,4,5-Trisphosphate/analogs & derivatives , Inositol 1,4,5-Trisphosphate/metabolism , Inositol 1,4,5-Trisphosphate Receptors/agonists , Inositol 1,4,5-Trisphosphate Receptors/metabolism , Lung/cytology , Lung/metabolism , Mice , Mice, Inbred BALB C , Muscle Relaxation/drug effects , Muscle, Smooth/cytology , Muscle, Smooth/metabolism , Phosphodiesterase Inhibitors/chemistry , Phosphodiesterase Inhibitors/pharmacology , Quaternary Ammonium Compounds/pharmacology , Receptors, G-Protein-Coupled/metabolism , Ryanodine/antagonists & inhibitors , Ryanodine/pharmacology , Taste
3.
J Antibiot (Tokyo) ; 63(2): 77-82, 2010 Feb.
Article in English | MEDLINE | ID: mdl-20057513

ABSTRACT

A new ryanodine-binding inhibitor, verticilide, was isolated from the cultured broth of a fungus, Verticillium sp. FKI-1033. It is a 24-membered ring cyclic depsipeptide, its structure being elucidated as cyclo[(2R)-2-hydroxyheptanoyl-N-methyl- L-alanyl](4). Verticilide inhibited ryanodine binding to ryanodine receptors in the cockroach at an IC(50) value of 4.2 microM, whereas inhibition against mouse ryanodine receptors was weak (IC(50)=53.9 microM).


Subject(s)
Depsipeptides/metabolism , Depsipeptides/pharmacology , Ryanodine Receptor Calcium Release Channel/metabolism , Ryanodine/antagonists & inhibitors , Verticillium/metabolism , Animals , Cell Membrane/metabolism , Cockroaches , Depsipeptides/chemistry , Mice , Molecular Biology , Muscle Fibers, Skeletal/metabolism , Protein Binding , Structure-Activity Relationship
4.
Bioorg Med Chem ; 11(13): 3029-37, 2003 Jul 03.
Article in English | MEDLINE | ID: mdl-12788371

ABSTRACT

Activation of ryanodine receptor (RyR) from skeletal muscle sarcoplasmic reticulum by adenosine and adenosine's metabolites was studied. The purines tested increased the [3H]-ryanodine binding as follows: xanthine>adenosine>adenine >inosine>/=uric acid>hypoxanthine. The enhanced [3H]-ryanodine binding did not involve change in the RyR-Ca(2+) sensitivity and was due mainly to lower values in the affinity constant (K(d)) that corresponded with an increase in the association rate constant (K(+1)). [3H]-ryanodine maximum binding (B(max)) was much less affected. Adenosine and inosine effects were dependent on the presence beta-glycosidic bond within the ribose ring, since the combination of adenine or hypoxanthine with ribose was not able to emulate the nucleosides' original activation. Competition experiments with AMP-PCP, a non-hydrolyzable analogue of ATP, evidenced a nucleotide's inhibitory influence on the adenosine and xanthine activation of the RyR. As a result of a Quantitative Structure-Activity Relationship (QSAR) study, we found a significant correlation between the modulation by adenosine and its metabolites on RyR activity and the components of their calculated dipole moment vector. Our results show that the ribose moiety and the dipole moment vector could be factors that make possible the modulation of the RyR activity by adenosine and its metabolites.


Subject(s)
Adenosine/analogs & derivatives , Adenosine/pharmacology , Muscle, Skeletal/chemistry , Ryanodine Receptor Calcium Release Channel/drug effects , Ryanodine/antagonists & inhibitors , Adenosine/chemistry , Animals , Binding, Competitive , Calcium/pharmacology , Muscle Fibers, Fast-Twitch/chemistry , Muscle, Skeletal/metabolism , Protein Binding/drug effects , Purines/pharmacology , Rabbits , Radioligand Assay , Ryanodine/metabolism , Ryanodine Receptor Calcium Release Channel/metabolism , Sarcoplasmic Reticulum/chemistry , Structure-Activity Relationship
5.
J Neurophysiol ; 88(3): 1077-87, 2002 Sep.
Article in English | MEDLINE | ID: mdl-12205130

ABSTRACT

6-((4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indacene-3-propionyl)amino)hexanoic acid ryanodine (BODIPY-ryanodine) binding and Ca(2+) imaging were used to study the properties of ryanodine receptors (RyRs) and cytoplasmic Ca(2+) (Ca) changes in neurons cultured from the embryonic rat hippocampus during the earliest stages of differentiation. Baseline Ca levels declined from 164 +/- 5 (SD) nM at early stages to 70 +/- 4 nM in differentiated neurons. Fluorescent BODIPY-ryanodine binding signals identified activated RyRs in somata, which were eliminated by removal of external Ca(2+) or by blockage of Ca(2+) entry through L-type but not N-type Ca(2+) channels. The GABA synthesis inhibitor 3-mercaptopropionic acid completely abolished ryanodine binding. Caffeine or K(+)-depolarization inhibited the activity of RyRs at very early stages of differentiation but had stimulatory effects at later stages after a network of processes had formed. BayK-8644 stimulated RyRs throughout all regions of all differentiating cells. The results suggest that in differentiating embryonic hippocampal neurons the activity of RyRs is maintained via Ca(2+) entering through L-type Ca(2+) channels. The mode of activation of L-type voltage-gated Ca(2+) channels with either membrane depolarization or specific pharmacological agents affects the coupled activity of RyRs differently as neurons differentiate processes and networks.


Subject(s)
Hippocampus/cytology , Hippocampus/metabolism , Neurons/cytology , Neurons/metabolism , Ryanodine Receptor Calcium Release Channel/metabolism , 3-Mercaptopropionic Acid/pharmacology , 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester/pharmacology , Animals , Caffeine/pharmacology , Calcium/metabolism , Calcium Channel Agonists/pharmacology , Calcium Channels, L-Type/metabolism , Cell Differentiation/physiology , Cells, Cultured , Potassium Chloride/pharmacology , Rats , Rats, Sprague-Dawley , Ryanodine/antagonists & inhibitors , Ryanodine/metabolism
6.
J Neurotrauma ; 19(3): 335-42, 2002 Mar.
Article in English | MEDLINE | ID: mdl-11939501

ABSTRACT

Calcium influx and elevation of intracellular free calcium (Ca2+i), with subsequent activation of degenerative enzymes is hypothesized to cause cell injury and death after trauma. We examined the effects of traumatic compressive injury on (Ca2+)i dynamics in spinal cord white matter. We conducted electrophysiological studies with ryanodine and inositol (1,4,5)-triphosphate (IP3) receptor agonists and antagonists in an in vitro model of spinal cord injury (SCI). A 25-30-mm length of dorsal column was isolated from the spinal cord of adult rats, pinned in an in vitro recording chamber (37 degrees C) and injured with a modified clip (2-g closing force) for 15 sec. The functional integrity of the dorsal column was monitored electrophysiologically by quantitatively measuring the compound action potential (CAP) with glass microelectrodes. The CAP decreased to 55.2+/-6.8% of control (p < 0.05) after spinal cord injury (SCI). Chelation of Ca2+i with BAPTA-AM (a high-affinity calcium chelator) promoted significantly greater recovery of CAP amplitude (83.2+/-4.2% of control; p < 0.05) after injury. Infusion of caffeine (1 and 10 mM) exacerbated CAP amplitude decline (45.1+/-5.9% of control; p < 0.05; 44.6+/-3.1% of control; p < 0.05) postinjury. Blockade of Ca2+i release through ryanodine-sensitive receptors (RyRs) with dantrolene (10 microM) and ryanodine (50 microM), conferred significant (p < 0.05) improvement in CAP amplitude after injury. On the other hand, blockade of Ca2+i with inositol (1,4,5)-triphosphate receptor (IP3Rs) blocker 2APB (10 microM) also conferred significant improvement in CAP amplitude after injury (82.9+/-7.9%; p < 0.05). In conclusion, the injurious effects of Ca2+i in traumatic central nervous system (CNS) white matter injury appear to be mediated both by RyRs and through IP3Rs calcium-induced calcium release receptors (CICRs).


Subject(s)
Calcium Channels/physiology , Calcium-Binding Proteins/physiology , Calcium/physiology , Egtazic Acid/analogs & derivatives , Receptors, Cytoplasmic and Nuclear/physiology , Ryanodine Receptor Calcium Release Channel/physiology , Spinal Cord Injuries/metabolism , Spinal Cord Injuries/physiopathology , Action Potentials/drug effects , Animals , Boron Compounds/pharmacology , Caffeine/pharmacology , Calcium-Binding Proteins/agonists , Calcium-Binding Proteins/antagonists & inhibitors , Central Nervous System Stimulants/pharmacology , Chelating Agents/pharmacology , Dantrolene/pharmacology , Egtazic Acid/pharmacology , Electrophysiology , In Vitro Techniques , Inositol 1,4,5-Trisphosphate Receptors , Male , Models, Animal , Muscle Relaxants, Central/pharmacology , Neural Conduction/drug effects , Rats , Rats, Wistar , Receptors, Cytoplasmic and Nuclear/agonists , Receptors, Cytoplasmic and Nuclear/antagonists & inhibitors , Ryanodine/agonists , Ryanodine/antagonists & inhibitors , Ryanodine/pharmacology
7.
Pflugers Arch ; 441(1): 108-17, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11205048

ABSTRACT

Previous reports have shown that cooling striated muscles induces contractile responses that are related to Ca2+ release from the sarcoplasmic reticulum. However, the effect of cooling has generally been studied in the presence of pharmacological agents that potentiate rapid cooling-induced contractures. The present study shows that in saponin-skinned rat skeletal muscle preparations, a drop in temperature from 22 degrees C to 2 degrees C per se induces a contracture which relaxes on return to 22 degrees C. In fast-twitch fibres, rapid cooling-induced contractures are fully blocked by ryanodine, an inhibitor of ryanodine receptors. By contrast, in slow-twitch fibres, ryanodine partially inhibits the rapid cooling-induced contractile response, leaving a residual tension that dissipates after application of inositol 1,4,5-trisphosphate (InsP3). At low concentrations, heparin, an inhibitor of InsP3 receptors, decreases rapid cooling-induced contractures in both types of muscle. The present results suggest that in skeletal muscle, rapid cooling-induced contractures are due to both ryanodine-sensitive and InsP3-sensitive Ca2+ release from the sarcoplasmic reticulum.


Subject(s)
Calcium Channels/physiology , Calcium/metabolism , Cold Temperature , Contracture/etiology , Receptors, Cytoplasmic and Nuclear/physiology , Ryanodine Receptor Calcium Release Channel/physiology , Sarcoplasmic Reticulum/metabolism , Animals , Calcium/pharmacology , Heparin/pharmacology , Inositol 1,4,5-Trisphosphate/pharmacology , Inositol 1,4,5-Trisphosphate Receptors , Male , Muscle Fibers, Fast-Twitch , Muscle Fibers, Skeletal , Muscle Fibers, Slow-Twitch , Muscle, Skeletal , Rats , Rats, Wistar , Receptors, Cytoplasmic and Nuclear/antagonists & inhibitors , Ryanodine/antagonists & inhibitors , Ryanodine/pharmacology , Saponins/pharmacology
8.
Biochem J ; 342 ( Pt 1): 239-48, 1999 Aug 15.
Article in English | MEDLINE | ID: mdl-10432322

ABSTRACT

Modification of the ryanodine receptor (RyR)/Ca(2+) release channel with 2,4-dinitrofluorobenzene (DNFB) indicated that two classes of amino group interact with the reagent, as can be distinguished on the basis of their reactivity/accessibility and the effects on ryanodine binding and single channel activities. One group interacted very rapidly (t(1/2)<30 s) at 25 degrees C with low concentrations of DNFB [C(50) (concentration of DNFB required for 50% inhibition or stimulation of ryanodine binding)=5 microM], and at pH values of 6.2 and higher. This interaction resulted in the marked stimulation of ryanodine binding and the complete inhibition of a single Ca(2+) release channel incorporated into planar lipid bilayer. The second group is accessible at higher temperatures (37 degrees C); at pH values higher than 7.4 it reacted slowly (t(1/2)=20 min) with high concentrations of DNFB (C(50)=70 microM). This interaction led to the inhibition of ryanodine binding and single channel activity. Modification of RyR with DNFB under the stimulatory conditions resulted in 3.6-fold and 6-fold increases in ryanodine-binding and Ca(2+)-binding affinities respectively. Modification with DNFB under the inhibitory conditions resulted in a decrease in the total ryanodine-binding sites. The exposure of the RyR single channel to DNFB under both inhibitory and stimulatory conditions led to the complete closure of the channel. However, when modified under the stimulatory conditions, but not under the inhibitory ones, the DNFB-modified closed channel could be re-activated by sub-micromolar concentrations of ryanodine, in the presence of nanomolar concentrations of Ca(2+). The DNFB-modified ryanodine-activated RyR channel showed fast transitions between open, closed and several sub-conductance states, and was completely closed by Ruthenium Red. ATP re-activated the DNFB-modified closed channel or, if present during modification, prevented the inhibition of RyR channel activity by DNFB. Neither the stimulation nor the inhibition of ryanodine binding by modification with DNFB was affected by the presence of ATP. By using the photoreactive ATP analogue 3'-O-(4-benzoyl)benzoyl-[alpha-(32)P]ATP we found that DNFB modification had no effect on the ATP-binding site of RyR. The results are discussed with regard to the involvement of amino group residues in channel gating, ryanodine association/dissociation and occlusion, and the relationship between the open/closed state of the RyR and its capacity to bind ryanodine.


Subject(s)
Dinitrofluorobenzene/metabolism , Ion Channel Gating , Ryanodine Receptor Calcium Release Channel/chemistry , Ryanodine Receptor Calcium Release Channel/metabolism , Adenosine Triphosphate/analogs & derivatives , Adenosine Triphosphate/metabolism , Adenosine Triphosphate/pharmacology , Amines/chemistry , Amines/metabolism , Calcium/metabolism , Calcium/pharmacology , Dinitrofluorobenzene/pharmacology , Dose-Response Relationship, Drug , Hydrogen-Ion Concentration , Ion Channel Gating/drug effects , Kinetics , Lipid Bilayers/chemistry , Lipid Bilayers/metabolism , Molecular Weight , Protein Conformation/drug effects , Ruthenium Red/pharmacology , Ryanodine/agonists , Ryanodine/antagonists & inhibitors , Ryanodine/metabolism , Ryanodine/pharmacology , Sarcoplasmic Reticulum/chemistry , Sarcoplasmic Reticulum/drug effects , Sarcoplasmic Reticulum/metabolism , Structure-Activity Relationship
9.
Biochem Biophys Res Commun ; 257(1): 57-62, 1999 Apr 02.
Article in English | MEDLINE | ID: mdl-10092509

ABSTRACT

Cyclic ADP-ribose (cADPR) elicits calcium-induced calcium release (CICR) in a variety of cell types. We studied the effect of cADPR on Ca2+ release in muscle cells by incubating SR vesicles from scallop (Pecten jacobaeus) adductor muscle in the presence of the Ca2+ tracer fluo-3. Exposure of SR to cADPR (20 microM) produced Ca2+ release, which was a function of free [Ca2+] in a range between about 150 and 1000 nM, indicating an involvement of ryanodine-sensitive Ca2+ channels. This Ca2+ release was not significantly enhanced by calmodulin (7 micrograms/ml), but it was enhanced by equimolar addition of noncyclic ADPR. Also, the Ca2+ release elicited by cADPR/ADPR was a function of free [Ca2+] in a range between about 150 and 3000 nM, over which Ca2+ was inhibitory. cADPR self-inactivation was observed at low free [Ca2+] (about 150 nM), but it tended to disappear upon [Ca2+] elevation (about 250 nM). Caffeine or ryanodine induced a Ca2+ release which was ruthenium red (2.5 microM) sensitive at low [Ca2+]. However, the Ca2+ release induced by either ryanodine or cADPR was no longer ruthenium red sensitive when free [Ca2+] was increased. Based on these data, a model is proposed for Ca2+ signaling in muscle cells, where a steady-state cADPR level would trigger Ca2+ release when free [Ca2+] does reach a threshold slightly above its resting level, hence producing cascade RyR recruitment along SR cisternae from initial Ca2+ signaling sites.


Subject(s)
Adenosine Diphosphate Ribose/analogs & derivatives , Antigens, CD , Calcium Signaling , Calcium/metabolism , Mollusca/metabolism , Sarcoplasmic Reticulum/metabolism , ADP-ribosyl Cyclase , ADP-ribosyl Cyclase 1 , Adenosine Diphosphate Ribose/metabolism , Adenosine Diphosphate Ribose/pharmacology , Aniline Compounds , Animals , Antigens, Differentiation/metabolism , Caffeine/antagonists & inhibitors , Caffeine/pharmacology , Calcimycin/pharmacology , Calcium/pharmacology , Calcium Signaling/drug effects , Calmodulin/pharmacology , Cyclic ADP-Ribose , Models, Biological , Mollusca/drug effects , NAD+ Nucleosidase/metabolism , Ruthenium Red/antagonists & inhibitors , Ruthenium Red/pharmacology , Ryanodine/antagonists & inhibitors , Ryanodine/pharmacology , Ryanodine Receptor Calcium Release Channel/physiology , Sarcoplasmic Reticulum/drug effects , Thapsigargin/pharmacology , Xanthenes
10.
Am J Physiol ; 276(3): H865-72, 1999 03.
Article in English | MEDLINE | ID: mdl-10070069

ABSTRACT

Chronic treatment with cyclosporin A (CsA) has been reported (H. S. Banijamali, M. H. ter Keurs, L. C. Paul, and H. E. ter Keurs. Cardiovasc. Res. 27: 1845-1854, 1993; I. Kingma, E. Harmsen, H. E. ter Keurs, H. Benediktsson, and L. C. Paul. Int. J. Cardiol. 31: 15-22, 1991) to induce reversible alterations of contractile properties in rat hearts. To define the molecular mechanisms underlying the physiological alterations, the Ca2+-release channel (CRC) and Ca2+-ATPase from sarcoplasmic reticulum in rats were examined. Ryanodine binding to whole homogenates of rat hearts shows time- and dose-dependent alterations in CRC properties by CsA. On 3 wk of treatment with 15 mg CsA. kg body wt-1. day-1, 1) maximal ryanodine binding (Bmax) decreased, 2) the dissociation constant of ryanodine (Kd) increased, 3) caffeine sensitivity of CRC increased, and 4) ruthenium red sensitivity of CRC decreased. On the other hand, Bmax and Kd of ryanodine binding in rat skeletal muscles were not changed. Ryanodine-sensitive oxalate-supported Ca2+ uptake in whole homogenates was lower in CsA-treated rat hearts than in control hearts, whereas total Ca2+ uptake in the presence of 500 M ryanodine was not changed. Functional experiments with rapamycin and Western blot analysis suggest that the CsA-induced alteration of ryanodine binding is due at least in part to an upregulation of calcineurin. The heart muscle-specific alterations of CRC could be responsible for the previously reported contractile changes of CsA-treated rat hearts.


Subject(s)
Calcium Channels/drug effects , Calcium Channels/metabolism , Cyclosporine/pharmacology , Immunosuppressive Agents/pharmacology , Myocardium/metabolism , Sarcoplasmic Reticulum/metabolism , Animals , Caffeine/pharmacology , Calcium/metabolism , Dose-Response Relationship, Drug , Male , Muscle, Skeletal/metabolism , Osmolar Concentration , Oxalates/pharmacology , Rats , Rats, Sprague-Dawley , Ruthenium Red/pharmacology , Ryanodine/antagonists & inhibitors , Ryanodine/metabolism , Sirolimus/pharmacology , Time Factors
11.
Naunyn Schmiedebergs Arch Pharmacol ; 357(2): 92-9, 1998 Feb.
Article in English | MEDLINE | ID: mdl-9521481

ABSTRACT

Ryanodine (10 microM), thapsigargin (1 microM) and cyclopiazonic acid (10 microM) produced a slow, sustained contractile response in rat aorta that only can be observed in Ca2+-containing solution. In Ca2+-free medium, no response to the drugs was obtained, which suggests that the contraction elicited in presence of Ca2+ is mainly due to the contribution of extracellular influx. This Ca2+ entry does not depend on the opening of dihydropyridine-dependent Ca2+-channels for nimodipine does not affect this. Noradrenaline (1 microM) induced a biphasic response in Ca2+-free medium that was mediated by two different Ca2+ compartments, one of which is common to caffeine (10 mM), and is also depleted by ryanodine (10 microM), thapsigargin (1 microM) and cyclopiazonic acid (10 microM). This compartment loses its Ca2+ content after long exposure (65 min) to Ca2+-free EDTA-containing solution and its refilling was also affected by the three agents tested. The other compartment depleted by noradrenaline, but not by caffeine, was also insensitive to ryanodine, thapsigargin and cyclopiazonic acid, and did not lose its Ca2+ after 65 min in Ca2+-free medium. Contractions induced by noradrenaline (1 microM) or caffeine (10 mM) in Ca2+-free medium were not affected by ryanodine, thapsigargin and cyclopiazonic acid when these agents were added 1 min before or during the response to each agonist. After depletion of internal Ca2+ stores sensitive to noradrenaline, an increase in the resting tone (IRT) of rat aorta was observed when Ca2+ was added again in absence of the agonist. This IRT was not affected by treatment with ryanodine, thapsigargin and cyclopiazonic acid, and represents a Ca2+ entry pathway dependent on the depletion of the noradrenaline-sensitive Ca2+ compartment. In conclusion, we can differentiate two Ca2+ entry pathways in rat aorta that depend on the previous depletion of two internal Ca2+ compartments: One corresponds to the classic capacitative Ca2+ entry model and is promoted by depletion of the internal pool sensitive to noradreanline, caffeine, ryanodine, thapsigargin and cyclopiazonic acid, the other is dependent only on depletion of an alpha1-adrenoceptor-sensitive Ca2+ pool.


Subject(s)
Aorta, Thoracic/metabolism , Calcium Channels/metabolism , Calcium/metabolism , Muscle, Smooth, Vascular/metabolism , Animals , Aorta, Thoracic/cytology , Aorta, Thoracic/drug effects , Caffeine/pharmacology , Calcium Channels/drug effects , In Vitro Techniques , Indoles/antagonists & inhibitors , Indoles/pharmacology , Male , Muscle Contraction/drug effects , Muscle, Smooth, Vascular/cytology , Muscle, Smooth, Vascular/drug effects , Norepinephrine/antagonists & inhibitors , Norepinephrine/pharmacology , Phosphodiesterase Inhibitors/pharmacology , Rats , Rats, Wistar , Ryanodine/antagonists & inhibitors , Ryanodine/pharmacology , Thapsigargin/antagonists & inhibitors , Thapsigargin/pharmacology , Vasoconstrictor Agents/antagonists & inhibitors , Vasoconstrictor Agents/pharmacology , Vasodilator Agents/antagonists & inhibitors , Vasodilator Agents/pharmacology
12.
Am J Physiol ; 272(5 Pt 1): C1465-74, 1997 May.
Article in English | MEDLINE | ID: mdl-9176136

ABSTRACT

The effect of D-erythro-C18-sphingosine (sphingosine) and related compounds on the Ca(2+)-release channel (ryanodine binding protein) was examined on rabbit skeletal muscle membranes, on the purified ryanodine binding protein, and on the channel reconstituted into planar lipid bilayers. Sphingosine inhibited [3H]ryanodine binding to sarcoplasmic reticulum (SR) membranes in a dose-dependent manner similar to published results (R. A. Sabbadini, R. Betto, A. Teresi, G. Fachechi-Cassano, and G. Salviati. J. Biol. Chem. 267: 15475-15484, 1992). The sphingolipid also inhibited [3H]ryanodine binding to the purified ryanodine binding protein. Our results demonstrate that the inhibition of [3H]ryanodine binding by sphingosine is due to an increased rate of dissociation of bound [3H]ryanodine from SR membranes and a decreased rate of association of [3H]ryanodine to the high-affinity site. Unlike other modulators of the Ca(2+)-release channel, sphingosine can remove bound [3H]ryanodine from the high-affinity site within minutes. Sphingosine increased the rate of dissociation of [3H]ryanodine bound to a solubilized proteolytic fragment derived from the carboxy terminus of the ryanodine binding protein (cleavage at Arg4475). Sphingosine also inhibited the activity of the Ca(2+)-release channel incorporated into planar lipid bilayers. Taken together, the data provide evidence for a direct effect of sphingosine on the Ca(2+)-release channel. Sphingosine is a noncompetitive inhibitor at the high-affinity ryanodine binding site, and it interacts with a site between Arg4475 and the carboxy terminus of the Ca(2+)-release channel.


Subject(s)
Calcium Channels/drug effects , Calcium Channels/metabolism , Muscle, Skeletal/metabolism , Sphingosine/pharmacology , Animals , Lipid Bilayers/metabolism , Rabbits , Ryanodine/antagonists & inhibitors , Ryanodine/metabolism , Sarcoplasmic Reticulum/metabolism , Sphingolipids/pharmacology
13.
Br J Pharmacol ; 118(4): 1019-27, 1996 Jun.
Article in English | MEDLINE | ID: mdl-8799577

ABSTRACT

1. The Ca2+ buffering function of sarcoplasmic reticulum (SR) in the resting state of arteries from spontaneously hypertensive rats (SHR) was examined. Differences in the effects of ryanodine that removes the function of SR, on tension and cellular Ca2+ level were assessed in endothelium-denuded strips of femoral arteries from 13-week-old SHR and normotensive Wistar-Kyoto rats (WKY). 2. The addition of ryanodine to the resting strips caused a concentration-dependent contraction in SHR. This contraction was extremely small in WKY. In the presence of 10(-5) M ryanodine, caffeine (20 mM) failed to cause a further contraction in SHR, but it caused a small contraction in WKY. After washout of the strips with a Krebs solution, the resting tone was greatly elevated in SHR when compared with WKY. 3. The elevated resting tone in SHR strips was abolished by 10(-7) M nifedipine. The ryanodine-induced contraction was also abolished by 10(-7) M nifedipine. Nifedipine itself caused a relaxation from the resting tone of SHR strips, suggesting the maintenance of myogenic tone. 4. In strips preloaded with fura-PE3, the addition of 10(-5) M ryanodine caused a large and moderate elevation of cytosolic Ca2+ level ([Ca2+]i) in SHR and WKY, respectively. After washout, the resting [Ca2+]i was greatly elevated in SHR. The ryanodine-induced elevation of [Ca2+]i was decreased by 5 x 10(-6) M verapamil in SHR. Verapamil itself caused a decrease in resting [Ca2+]i which was significantly greater in SHR than in WKY, and caused a relaxation only in SHR. 5. The resting Ca2+ influx in arteries measured by a 5 min incubation with 45Ca was significantly increased in SHR when compared with WKY. The resting Ca2+ influx was not increased by 10(-5) M ryanodine in both SHR and WKY. The net cellular Ca2+ uptake in arteries measured by a 30 min incubation with 45Ca was decreased by 10(-5) M ryanodine in both strains. 6. The resting Ca2+ influx was decreased by 10(-7) M nifedipine in the SHR artery, but it was unchanged in the WKY artery. 7. These results suggest that (1) the Ca2+ influx via L-type voltage-dependent Ca2+ channels was increased in the resting state of the SHR femoral artery, (2) the greater part of the increased Ca2+ influx was buffered by Ca2+ uptake into the SR and some Ca2+ reached the myofilaments resulting in the maintenance of the myogenic tone, and (3) therefore the functional removal of SR by ryanodine caused a potent contraction in this artery.


Subject(s)
Calcium/metabolism , Muscle Contraction , Muscle, Smooth, Vascular/drug effects , Ryanodine/pharmacology , Animals , Caffeine/pharmacology , Calcium Channel Blockers/pharmacology , Calcium Channels , Femoral Artery/drug effects , Male , Muscle Contraction/drug effects , Muscle Relaxation , Nifedipine/pharmacology , Phosphodiesterase Inhibitors/pharmacology , Rats , Rats, Inbred SHR , Rats, Inbred WKY , Ryanodine/antagonists & inhibitors , Sarcoplasmic Reticulum/metabolism , Verapamil/pharmacology
14.
Sci China B ; 37(1): 29-36, 1994 Jan.
Article in English | MEDLINE | ID: mdl-8068184

ABSTRACT

Early afterdepolarization (EAD) in mouse atrial fibers was investigated under the treatment with aconitine, 3.0 mmol/L K+, quinidine, ryanodine or Bay k 8644. All of these EADs possessed the following common characteristics: all the parameters of EAD showed cycle length-dependence; take-off potential of the first triggered burst played an important role in the generation of the other parameters; hyperpolarization of the triggered brust enhanced the end of EAD; and the second plateau response might be used as an indicator of the capability of EAD generation of myocardiac cell. All those EADs were inhibited or abolished by nifedipine, tetrodotoxin or lidocaine. Potassium channel activators, lemakalim, thalium ion, acetyl-choline or high potassium could also inhibit or abolish the EADs. It is suggested that the EADs induced by different agents may base on a common mechanism: all currents contributing to the plateau phase of the action potential play an important role in the generation of EAD.


Subject(s)
Heart/physiology , Aconitine/antagonists & inhibitors , Action Potentials/drug effects , Animals , Atrial Function , Benzopyrans/pharmacology , Cromakalim , Electrophysiology , Female , Male , Mice , Nifedipine/pharmacology , Pyrroles/pharmacology , Quinidine/antagonists & inhibitors , Ryanodine/antagonists & inhibitors , Tetrodotoxin/pharmacology
15.
J Gen Physiol ; 102(6): 1031-56, 1993 Dec.
Article in English | MEDLINE | ID: mdl-7510773

ABSTRACT

The effects of ruthenium red and the related compounds tetraamine palladium (4APd) and tetraamine platinum (4APt) were studied on the ryanodine activated Ca2+ release channel reconstituted in planar bilayers with the immunoaffinity purified ryanodine receptor. Ruthenium red, applied at submicromolar concentrations to the myoplasmic side (cis), induced an all-or-none flickery block of the ryanodine activated channel. The blocking effect was strongly voltage dependent, as large positive potentials that favored the movement of ruthenium red into the channel conduction pore produced stronger block. The half dissociation constants (Kd) for ruthenium red block of the 500 pS channel were 0.22, 0.38, and 0.62 microM, at +100, +80, and +60 mV, respectively. Multiple ruthenium red molecules seemed to be involved in the inhibition, because a Hill coefficient of close to 2 was obtained from the dose response curve. The half dissociation constant of ruthenium red block of the lower conductance state of the ryanodine activated channel (250 pS) was higher (Kd = 0.82 microM at +100 mV), while the Hill coefficient remained approximately the same (nH = 2.7). Ruthenium red block of the channel was highly asymmetric, as trans ruthenium red produced a different blocking effect. The blocking and unblocking events (induced by cis ruthenium red) can be resolved at the single channel level at a cutoff frequency of 2 kHz. The closing rate of the channel in the presence of ruthenium red increased linearly with ruthenium red concentration, and the unblocking rate of the channel was independent of ruthenium red concentrations. This suggests that ruthenium red block of the channel occurred via a simple blocking mechanism. The on-rate of ruthenium red binding to the channel was 1.32 x 10(9) M-1 s-1, and the off-rate of ruthenium red binding was 0.75 x 10(3) s-1 at +60 mV, in the presence of 200 nM ryanodine. The two related compounds, 4APd and 4APt, blocked the channel in a similar way to that of ruthenium red. These compounds inhibited the open channel with lower affinities (Kd = 170 microM, 4APd; Kd = 656 microM, 4APt), and had Hill coefficients of close to 1. The results suggest that ruthenium red block of the ryanodine receptor is due to binding to multiple sites located in the conduction pore of the channel.


Subject(s)
Calcium Channel Blockers , Muscles/metabolism , Ruthenium Red/pharmacology , Ryanodine/antagonists & inhibitors , Animals , Calcium Channels/isolation & purification , Calcium Channels/metabolism , Chromatography, Affinity , Electrophysiology , Immunochemistry , In Vitro Techniques , Kinetics , Membrane Potentials/drug effects , Muscle Proteins/isolation & purification , Muscle Proteins/metabolism , Muscles/drug effects , Nitrogen Compounds/pharmacology , Organometallic Compounds/pharmacology , Platinum Compounds/pharmacology , Rabbits , Ryanodine/pharmacology , Ryanodine Receptor Calcium Release Channel
16.
Br J Pharmacol ; 102(4): 788-90, 1991 Apr.
Article in English | MEDLINE | ID: mdl-1906767

ABSTRACT

Pinacidil, a potassium-channel opener, inhibited the ryanodine-sensitive oscillatory outward potassium current induced by Ca released from an intracellular store. Glibenclamide, a blocker of the ATP-sensitive K-channel, prevented the action of pinacidil, suggesting the presence of an additional site (to K channels) for the vasodilator actions of pinacidil at which glibenclamide can act as an antagonist.


Subject(s)
Glyburide/pharmacology , Guanidines/pharmacology , Muscle, Smooth, Vascular/metabolism , Potassium Channels/drug effects , Ryanodine/antagonists & inhibitors , Vasodilator Agents/pharmacology , Adenosine Triphosphate/pharmacology , Animals , Calcium/physiology , Guanidines/antagonists & inhibitors , In Vitro Techniques , Muscle, Smooth, Vascular/drug effects , Pinacidil , Portal Vein/drug effects , Portal Vein/metabolism , Rabbits
17.
Methods Find Exp Clin Pharmacol ; 12(8): 551-5, 1990 Oct.
Article in English | MEDLINE | ID: mdl-2093134

ABSTRACT

The effects of ryanodine on the action potential and induction of early afterdepolarization (EAD) were studied in the atrial fibers of mouse heart. Under treatment with ryanodine, the duration of the action potential (ADP) was prolonged. The percentage of the prolongation of ADP25, APD50 and ADP100 were 83, 49 and 20%, respectively, at a cycle length of 1 sec driving stimulation. As the cycle length was prolonged (from 0.5-10 sec), EAD could be induced in 10 of 16 preparations showing exponential relationship with the cycle length. Tetrodotoxin, lidocaine and nifedipine inhibited the induction of EAD. In 6 preparations in which the EAD was not induced, more than one burst could respond to a single premature stimulation applied in the early phase of repolarization, which was defined as second plateau response. The mechanism of ryanodine-induced EAD has been investigated.


Subject(s)
Heart/drug effects , Ryanodine/pharmacology , Action Potentials/drug effects , Animals , Female , Heart Atria/drug effects , In Vitro Techniques , Lidocaine/pharmacology , Male , Mice , Nifedipine/pharmacology , Ryanodine/antagonists & inhibitors , Tetrodotoxin/pharmacology
18.
Biochem J ; 268(3): 699-705, 1990 Jun 15.
Article in English | MEDLINE | ID: mdl-2163620

ABSTRACT

A light hepatic microsomal preparation was fractionated by sucrose-density centrifugation into one rough, one intermediate and two smooth fractions. The four fractions were characterized with respect to parameters relevant to Ca2+ sequestration. Ca2(+)-ATPase activity was similar in the rough, intermediate and smooth I fractions, but lower in the smooth II fraction. Ca2+ accumulation was the highest in the smooth I and intermediate fractions. On the other hand, Ca2+ efflux from the rough fraction was several-fold faster than from the smooth I fraction. All four subfractions exhibited specific binding sites for inositol 1,4,5-trisphosphate (IP3) and ryanodine; however, the receptors were especially enriched in the smooth I fraction. The total binding sites for ryanodine in that fraction exceeded the number of binding sites for IP3 by about 10-fold. The two receptors responded differently to pharmacological agents; caffeine and dantrolene strongly inhibited ryanodine binding but not IP3 binding, whereas heparin inhibited IP3 binding only. Thus the two receptors are distinct entities. The four fractions also showed distinct gel electrophoretic patterns. The use of two different SDS/polyacrylamide-gel gradients and two protein-staining methods revealed major differences in the distribution of the bands corresponding to Mr values of (x 10(-3) 380, 320, 260, 170, 90, 29 and 21. These proteins were enriched in the smooth fraction. The results indicate that the smooth I fraction might have special importance in stimulus-evoked Ca2(+)-release processes.


Subject(s)
Calcium Channels , Calcium/metabolism , Inositol 1,4,5-Trisphosphate/metabolism , Microsomes, Liver/metabolism , Receptors, Cell Surface/metabolism , Receptors, Cholinergic/metabolism , Receptors, Cytoplasmic and Nuclear , Animals , Calcium-Transporting ATPases/metabolism , Inositol 1,4,5-Trisphosphate/antagonists & inhibitors , Inositol 1,4,5-Trisphosphate Receptors , Male , Microsomes, Liver/enzymology , Microsomes, Liver/ultrastructure , Rats , Rats, Inbred Strains , Receptors, Cell Surface/drug effects , Receptors, Cholinergic/drug effects , Ryanodine/antagonists & inhibitors , Ryanodine/metabolism , Ryanodine Receptor Calcium Release Channel , Sodium-Potassium-Exchanging ATPase/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...